HC Wainwright reaffirmed their buy rating on shares of Daré Bioscience (NASDAQ:DARE – Get Rating) in a report published on Friday morning, Benzinga reports. They currently have a $7.00 target price on the biotechnology company’s stock. HC Wainwright also issued estimates for Daré Bioscience’s FY2027 earnings at $0.80 EPS. Several other research firms have also […]
Related Keywords
Lisa Walters Hoffert , Sabrina Martucci Johnson , Founders Financial Securities , Renaissance Technologies , Bioscience Inc , Pricet Rowe Associates Inc , Northern Trust Corp , Get Rating , Capital Management , Bioscience Price , Financial Securities , Street Corp , Trust Corp , Pricet Rowe Associates , Bioscience Daily , Daré Bioscience , Nasdaq Dare , Dare , Medical , Reiterated Rating , Hc Wainwright ,
comparemela.com © 2020. All Rights Reserved.